A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection

Journal of General Virology

Volumn 84, Issue 8, 2003, Pages 1973-1983

  Reading, Patrick C ^a,b   Smith, Geoffrey L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CYTOKINE; GAMMA INTERFERON; LIGAND; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; EXTERNAL EAR; FEMALE; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; LUNG INFECTION; LUNG LAVAGE; MACROPHAGE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; NOSE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REVIEW; SKIN INFECTION; T LYMPHOCYTE; UPPER RESPIRATORY TRACT INFECTION; VACCINIA VIRUS; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS STRAIN; VISCERA;

ADMINISTRATION, INTRANASAL; ANIMALS; CHEMOKINES; DISEASE MODELS, ANIMAL; EAR; FEMALE; INFLAMMATION; INJECTIONS, INTRADERMAL; LEUKOCYTES; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY TRACT INFECTIONS; SKIN; SKIN DISEASES, VIRAL; VACCINIA; VACCINIA VIRUS; VIRULENCE;

ANIMALIA; DNA VIRUSES; VACCINIA VIRUS;

EID: 0042668555     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19285-0     Document Type: Review

References (44)

1. Alcamí, A. & Smith, G. L. (1992). A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167.
2. Alcamí, A. & Smith, G. L. (1995). Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69, 4633-4639.
3. Alcamí, A. & Koszinowski, U. H. (2000). Viral mechanisms of immune evasion. Trends Microbiol 8, 410-418.
4. Alcamí, A., Khanna, A., Paul, N. L. & Smith, G. L. (1999). Vaccinia virus strains Lister, USSR and Evans express soluble and cell surface tumour necrosis factors receptor. J Gen Virol 80, 949-959.
5. Baggiolini, M. (1998). Chemokines and leukocyte traffic. Nature 392, 565-568.
6. Baxby, D. (1981). Jenner's Smallpox Vaccine. The Riddle of the Origin of Vaccinia Virus. London: Heinemann.
7. Belkaid, Y., Jouin, H. & Milon, G. (1996). A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J Immunol Methods 199, 5-25.
8. Belkaid, Y., Kamhawi, S., Modi, G., Valenzuela, J., Noben-Trauth, N., Rowton, E., Ribeiro, J. & Sacks, D. L. (1998). Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 188, 1941-1953.
9. Bronson, L. H. & Parker, R. F. (1941). The neutralization of vaccine virus by immune serum: titration by the intracerebral inoculation of mice. J Bacteriol 41, 56-57.
10. Buller, R. M., Smith, G. L., Cremer, K, Notkins, A. L. & Moss, B. (1985). Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317, 813-815.
11. Carr, M. W., Roth, S. J., Luther, E., Rose, S. S. & Springer, T. A. (1994). Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 91, 3652-3656.
12. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A. & Stewart, T. A. (1993). Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739-1742.
13. Ding, A. H., Nathan, C. F. & Stuehr, D. J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141, 2407-2412.
14. Fenner, F., Wittek, R. & Dumbell, K. R. (1989). The Orthopoxviruses. London: Academic Press.
15. Haeberle, H. A., Kuziel, W. A., Dieterich, H. J., Casola, A., Gatalica, Z. & Garofalo, R. P. (2001). Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1α in lung pathology. J Virol 75, 878-890.
16. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M. & Aguet M. (1993). Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742-1745.
17. Karupiah, G. & Harris, N. (1995). Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med 181, 2171-2179.
18. Karupiah, G., Blanden, R. V. & Ramshaw, I. A. (1990). Interferon-γ is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med 172, 1495-1503.
19. Lee, M. S., Roos, J. M., McGuigan, L. C., Smith, K. A., Cormier, L., Cohen, K., Roberts, B. E. & Payne, L. G. (1992). Molecular attenuation of vaccinia virus: mutant generation and animal characterization. J Virol 66, 2617-2630.
20. Mackett, M., Smith, G. L. & Moss, B. (1985). The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: a Practical Approach, pp. 191-211. Edited by D. M. Glover. Oxford: IRL Press.
21. Melkova, Z. & Esteban, M. (1994). Interferon-gamma severely inhibits DNA synthesis of vaccinia virus in a macrophage cell line. Virology 198, 731-735.
22. Miyazato, A., Kawakami, K., Iwakura, Y. & Saito, A. (2000). Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T-lymphotropic virus type 1. Clin Exp Immunol 120, 113-124.
23. Mossman, K., Upton, C., Buller, R. M. & McFadden, G. (1995). Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 208, 762-769.
24. Reading, P. C., Khanna, A. & Smith, G. L. (2002). Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology 292, 285-298.
25. Reading, P. C., Symons, J. A. & Smith, G. L. (2003). A soluble chemokine-binding protein from vaccinia virus reduces virulence and the inflammatory response to infection. J Immunol 170, 1435-1442.
26. Rollins, B. J., Yoshimura, T., Leonard, E. J. & Pober, J. S. (1990). Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 136, 1229-1233.
27. Rolph, M. S., Cowden, W. B., Medveczky, C. J. & Ramshaw, I. A. (1996). A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J Virol 70, 7678-7685.
28. Rossi, D. & Zlotnik, A. (2000). The biology of chemokines and their receptors. Annu Rev Immunol 18, 217-242.
29. Ruby, J. & Ramshaw, I. (1991). The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine Res 10, 353-358.
30. Sarawar, S. R., Lee, B. J., Anderson, M., Teng, Y. C., Zuberi, R. & Von Gesjen, S. (2002). Chemokine induction and leukocyte trafficking to the lungs during murine gammaherpesvirus 68 (MHV-68) infection. Virology 293, 54-62.
31. Sarmiento, M., Glasebrook, A. L. & Fitch, F. W. (1980). IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 125, 2665-2672.
32. Schall, T. J., Bacon, K, Camp, R. D., Kaspari, J. W. & Goeddel, D. V. (1993). Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 177, 1821-1826.
33. Selin, L. K., Santolucito, P. A., Pinto, A. K., Szomolanyi-Tsuda, E. & Welsh, R. M. (2001). Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol 166, 6784-6794.
34. Smith, G. L. (2000). Secreted poxvirus proteins that interact with the immune system. In Effects of Microbes on the Immune System, pp. 491-507. Edited by M. W. Cunningham & R. S. Fujinami. Philadelphia: Lippincott Williams & Wilkins.
35. Smith, V. P., Bryant N. A. & Alcamí, A. (2000). Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18- binding proteins. J Gen Virol 81, 1223-1230.
36. Symons, J. A., Tscharke, D. C., Price, N. & Smith, G. L. (2002a). A study of the vaccinia virus interferon-γ receptor and its contribution to virus virulence. J Gen Virol 83, 1953-1964.
37. Symons, J. A., Adams, E, Tscharke, D. C., Reading, P. C., Waldmann, H. & Smith, G. L. (2002b). The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virulence in a mouse intranasal model. J Gen Virol 83, 2833-2844.
38. Takanami-Ohnishi, Y., Amano, S., Kimura, S., Asada, S., Utani, A., Maruyama, M., Osada, H., Tsunoda, H., Irukayama-Tomobe, Y., Goto, K., Karin, M., Sudo, T. & Kasuya, Y. (2002). Essential role of p38 mitogen-activated protein kinase in contact hypersensitivity. J Biol Chem 277, 37896-37903.
39. Tripp, R. A., Jones, L. & Anderson, L. J. (2000). Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J Virol 74, 6227-6229.
40. Tscharke, D. C. & Smith, G. L. (1999). A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 80, 2751-2755.
41. Tscharke, D. C., Reading, P. C. & Smith, G. L. (2002). Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol 83, 1977-1986.
42. Turner, G. S. (1967). Respiratory infection of mice with vaccinia virus. J Gen Virol 1, 399-402.
43. Weinberg, J. B., Lutzke, M. L., Efstathiou, S., Kunkel, S. L. & Rochford, R. (2002). Elevated chemokine responses are maintained in lungs after clearance of viral infection. J Virol 76, 10518-10523.
44. Williamson, J. D., Reith, R. W., Jeffrey, L. J., Arrand, J. R. & Mackett, M. (1990). Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J Gen Virol 71, 2761-2767.